Immunogenicity Study of a Three-Dose Subcutaneous BioThrax Regimen for Post-Exposure Prophylaxis in Healthy Adults

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/06 → 9/30/12

Funding

  • DP Clinical Inc: $150,143.00